BI 1819479
Idiopathic Pulmonary Fibrosis · ANZCTR
Clinical trials
1
Mechanism
ANZCTR
Developer
Boehringer Ingelheim
Overview
BI 1819479 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via anzctr. It appears in 1 tracked IPF clinical trial.
BI 1819479 clinical trials
Explore related
Medical disclaimer. This page summarizes research about BI 1819479 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.